DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	106	108	42	99	190	58
Market Cap Growth	159.71%	157.97%	-57.63%	-48.10%	226.30%	69.03%
Enterprise Value	60	55	9	54	163	50
PE Ratio	-	-5.58	-3.05	-7.23	-15.45	-5.47
PB Ratio	2.29	2.11	1.31	2.24	7.30	7.65
P/FCF Ratio	-5.17	-5.75	-3.60	-8.04	-20.62	-6.41
P/OCF Ratio	-5.18	-5.76	-3.63	-8.05	-20.69	-6.40
EV/EBITDA Ratio	-3.09	-2.89	-0.64	-3.96	-13.33	-4.78
EV/EBIT Ratio	-3.07	-2.87	-0.64	-3.93	-13.25	-4.75
EV/FCF Ratio	-2.90	-2.95	-0.75	-4.36	-17.64	-5.55
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	0.02
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	0.00	-0.01	-0.02
Debt / FCF Ratio	-0.02	-0.02	-0.04	0.00	-0.01	-0.02
Quick Ratio	17.93	19.12	15.49	29.69	13.74	6.67
Current Ratio	18.14	19.27	15.61	29.82	13.77	6.70
Return on Equity (ROE)	-36.20%	-39.90%	-37.70%	-40.60%	-61.20%	-99.20%
Return on Assets (ROA)	-34.50%	-37.70%	-35.80%	-38.90%	-57.00%	-88.00%
Return on Capital (ROIC)	-45.98%	-41.33%	-43.35%	-30.96%	-48.60%	-148.72%
Earnings Yield	-18.13%	-17.91%	-32.79%	-13.83%	-6.47%	-18.28%
FCF Yield	-19.11%	-17.40%	-27.74%	-12.44%	-4.85%	-15.61%
Buyback Yield / Dilution	-43.51%	-23.16%	-27.29%	-32.48%	-30.80%	-54.81%
Total Shareholder Return	-43.51%	-23.16%	-27.29%	-32.48%	-30.80%	-54.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).